Lu Lu, Su Shan, Yang Haitao, Jiang Shibo
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, Shanghai Tech University, Shanghai 201210, China.
Cell. 2021 Mar 18;184(6):1604-1620. doi: 10.1016/j.cell.2021.02.013.
Historically, emerging viruses appear constantly and have cost millions of human lives. Currently, climate change and intense globalization have created favorable conditions for viral transmission. Therefore, effective antivirals, especially those targeting the conserved protein in multiple unrelated viruses, such as the compounds targeting RNA-dependent RNA polymerase, are urgently needed to combat more emerging and re-emerging viruses in the future. Here we reviewed the development of antivirals with common targets, including those against the same protein across viruses, or the same viral function, to provide clues for development of antivirals for future epidemics.
从历史上看,新兴病毒不断出现,已夺走数百万人类生命。目前,气候变化和高度全球化为病毒传播创造了有利条件。因此,迫切需要有效的抗病毒药物,尤其是那些针对多种不相关病毒中保守蛋白的药物,如靶向RNA依赖性RNA聚合酶的化合物,以应对未来更多的新兴和再发病毒。在此,我们综述了具有共同靶点的抗病毒药物的研发情况,包括针对不同病毒中相同蛋白或相同病毒功能的药物,为未来疫情防控的抗病毒药物研发提供线索。